DGAP-News: Callista Private Equity GmbH & Co. KG acquires

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-News: Callista Private Equity GmbH & Co. KG acquires majority stake in Reederei Peter Deilmann and DEUTSCHLAND ++ Managing Director Christopher Nolde takes a stake in the company

DGAP-News: Callista Private Equity GmbH & Co. KG / Key word(s): Acquisition Callista Private Equity GmbH & Co. KG acquires majority stake in Reederei Peter Deilmann and DEUTSCHLAND ++ Managing Director Christopher Nolde takes a stake in the company 08.01.2014 / 19:08 --------------------------------------------------------------------- -Callista Private Equity acquires majority stake in Reederei Peter Deilmann and DEUTSCHLAND -Name recognition, service and long-term profitability form the basis for further company success -Managing Director Christopher Nolde takes a stake in the company Munich, January 8, 2014 - Callista Private Equity GmbH & Co. KG ('Callista Private Equity') is pleased to announce the acquisition from AURELIUS AG ('AURELIUS') of a majority interest in MS Deutschland Holding, and hence in MS 'Deutschland' Beteiligungsgesellschaft mbH ('MS Deutschland GmbH'), to which both Reederei Peter Deilmann and the cruise liner MS DEUTSCHLAND belong. The DEUTSCHLAND is well known in the German-speaking world as the 'Traumschiff' from a popular TV series of the same name. The parties have agreed not to reveal the purchase price. The transaction was preceded by a due diligence process and lengthy discussions between the parties lasting several weeks. The acquisition of a majority interest by Callista Private Equity is intended to continue the restructuring successfully initiated by AURELIUS in 2010. Following initial success, Callista Private Equity aims to press ahead with the strategy that has been applied by implementing further measures on both the operational and strategic sides. Callista Private Equity is also planning to inject more capital into the company by reinforcing the equity component with a view to permanently underpinning the growth course that has been set. Under the terms of the transaction, Christopher Nolde, Managing Director of MS Deutschland GmbH, is taking a stake in the company and will continue to apply its growth-based reorientation strategy. 'There a very few German brands that embody dreams and desires for the finer things in life like the Traumschiff, and AURELIUS has achieved considerable success together with the management team since acquiring the company in 2010. Nevertheless, there is still plenty to do and the DEUTSCHLAND is a very demanding management task overall,' says Olaf Meier, CEO of Callista Private Equity. He adds: 'With the many years of experience we have gained in successful company development, we specialize in situations like this. Callista Private Equity is keen to promote continuity and successful performance over the long run, so we're delighted that Mr. Nolde has agreed to remain CEO of the company. What's more, the DEUTSCHLAND is an attractive ship with a fantastic underlying brand and an outstanding team. The latest marketing trends for the luxury cruise ship the DEUTSCHLAND are very positive. This is reinforced by the fact that various factors constraining the cruise industry in 2013 are no longer applicable overall. Against this backdrop, Callista Private Equity believes this is a good time to invest in the DEUTSCHLAND.' Callista Private Equity intends to further strengthen the DEUTSCHLAND and Reederei Peter Deilmann brands and sustainably boost the earnings of the corporate group. The orientation and positioning of the DEUTSCHLAND as a 'grand hotel of the high seas' will be retained under Callista Private Equity in order to ensure that the passengers continue to enjoy the usual high level of service or even better. About Callista Private Equity Callista Private Equity GmbH & Co.KG ('Callista Private Equity'), headquartered in Munich, acquires distressed companies, non-core group assets and business units. The companyâ??s success is based on the subsequent restructuring process. Callista Private Equity employs a team of experienced international experts to reorganize the operations of the acquired company and concentrate on restructuring resulting in sustainable profitability. To find out more, visit www.callista-pe.de Contact: Axel Mühlhaus T: +49 69 9055-0552 E: amuehlhaus@edicto.de About MS 'Deutschland' Beteiligungsgesellschaft mbH MS 'Deutschland' Beteiligungsgesellschaft mbH, headquartered in Neustadt in Holstein (Germany), operates cruises worldwide throughout the year as the owner of the ocean cruise liner MS DEUTSCHLAND, also known as the 'Traumschiff' from the television series of the same name. With a length of 175m and a width of 23m, the MS DEUTSCHLAND as 'grand hotel of the high seas' has a total of 294 passenger cabins. The ship received the award of 'Best Ship of 2013' from both the Lufthansa City Center travel agencies and Diners Club. With Reederei Peter Deilmann GmbH, Touristik-Bureau International GmbH and Deutsche Kreuzfahrt Management Services GmbH, MS 'Deutschland' Beteiligungsgesellschaft mbH also includes fully-owned subsidiaries that look after sales, marketing and operation of the cruise ship. To find out more, visit www.msdeutschland-gmbh.de Contact: Nicholas Wenzel T: +49 89 599458115 E: nicholas.wenzel@cnc-communications.com About AURELIUS AURELIUS has been successfully operating in the international market for company acquisitions for many years. The focus is on companies and corporate spin-offs in markets with plenty of potential for development. Once under the AURELIUS umbrella, the acquisitions are given a long-term strategic orientation and their potential developed. Building on active operational support, the subsidiaries benefit from the management experience and financial strength of the parent company. This is what makes AURELIUS a 'good home' for companies and their employees. At present, the AURELIUS Group encompasses 17 subsidiaries around the globe with facilities in Europe, Asia and the United States. Among others, these include traditional names like Blaupunkt and Berentzen together with numerous industrial enterprises. Companies are acquired in accordance with strict investment criteria, although there is no specific industry focus. Shares of AURELIUS AG are listed in the m:access segment of the Munich Stock Exchange and are traded on all German stock exchanges under ISIN DE000A0JK2A8. To find out more, visit www.aureliusinvest.de. Contact: Anke Banaschewski Investor Relations & Corporate Communications T: +49 89 544799 - 0 E: investor@aureliusinvest.de End of Corporate News --------------------------------------------------------------------- 08.01.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- 247328 08.01.2014

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 33

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Precious Metals and Energy Investors' Strategies

Updated Category News Views 143

Current Trends in Precious Metals The appeal of precious metals like gold and silver continues to gather momentum, particularly in light of recent global events. Many analysts believe that geopolitical tensions have created a catalyst for increased interest in gold as a safe haven. As governments grapple with economic challenges, investors are keenly observing changes in...

Continue Reading
Understanding P/E Ratios in the Context of Casey's General Stores

Updated Category News Views 175

Analyzing P/E Ratios for Investment Decisions In today’s market, understanding the performance metrics of stocks is vital. Currently, Casey's General Stores Inc. (NASDAQ: CASY) is noted at an impressive share price of $536.66. This reflects a modest increase of 0.33%. In examining market trends, the past month saw a slight decline of 4.39% in share value. However,...

Continue Reading
China's New Lending Outlook: Economic Recovery Strategies

Updated Category News Views 135

China's Recent New Lending Trends Recent updates reveal a significant rise in new bank lending in China. However, it didn't quite meet expectations, as analysts had hoped for a stronger performance. After disappointing figures in July, which hit a 15-year low, new data shows that Chinese banks issued around 900 billion yuan (approximately $126.86 billion) in new loans in...

Continue Reading
ParkOhio Shares Important Quarterly Dividend News for Investors

Updated Category News Views 177

ParkOhio Holdings Announces Latest Dividend Declaration Park-Ohio Holdings Corp. (NASDAQ: PKOH) recently declared a significant quarterly cash dividend of $0.125 per share to its common stockholders. This distribution demonstrates the company's ongoing commitment to providing returns to its shareholders. This dividend will be payable soon, marking another positive...

Continue Reading
Investigation Launched for Tourmaline Bio's Shareholders

Updated Category News Views 259

Investigation Overview on Tourmaline Bio, Inc. Recently, Monteverde & Associates PC, a renowned law firm, has initiated an investigation concerning Tourmaline Bio, Inc. (NASDAQ: TRML) and its proposed sale to Novartis AG. This potential acquisition raises several questions about the fairness of the deal, specifically regarding the cash payment offered to shareholders....

Continue Reading